Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125900051 | 12590005 | 1 | I | 20160117 | 20160718 | 20160725 | 20160725 | EXP | PHHY2016CN100853 | NOVARTIS | 63.00 | YR | F | Y | 0.00000 | 20160725 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125900051 | 12590005 | 1 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 200 MG, QD | 1200 | MG | N | X0920 | 16608 | 200 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125900051 | 12590005 | 1 | Trigeminal neuralgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125900051 | 12590005 | OT |
| 125900051 | 12590005 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125900051 | 12590005 | Diarrhoea | |
| 125900051 | 12590005 | Dizziness | |
| 125900051 | 12590005 | Erythema multiforme | |
| 125900051 | 12590005 | Laryngeal oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125900051 | 12590005 | 1 | 20160112 | 20160117 | 0 |